Hypoglycemic Coma in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib / 대한내과학회지
Korean Journal of Medicine
; : 501-504, 2014.
Article
Dans Ko
| WPRIM
| ID: wpr-176485
Responsable en Bibliothèque :
WPRO
ABSTRACT
We present a patient with type 2 diabetes mellitus and metastatic renal cell carcinoma who developed severe hypoglycemia and metabolic encephalopathy after sunitinib treatment. Sunitinib, a multi-target tyrosine kinase inhibitor, is used to treat metastatic renal cell carcinoma. Sunitinib-induced hypoglycemia has been reported and there are rare case reports of severe hypoglycemia due to sunitinib. Therefore, glycemic control should be monitored closely in diabetic patients treated with sunitinib.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Encéphalopathies métaboliques
/
Protein-tyrosine kinases
/
Néphrocarcinome
/
Coma
/
Diabète de type 2
/
Hypoglycémie
Limites du sujet:
Humans
langue:
Ko
Texte intégral:
Korean Journal of Medicine
Année:
2014
Type:
Article